$BIIB Headlines One lesson for investors from the 1990s

New Post Public Reply Private Reply Replies (0) Message Board

Jun 27, 2014 at 12:51 PM

$BIIB Headlines

One lesson for investors from the 1990s bubble 3:13 p.m. June 19, 2014 - The Trading Deck
Tyson rallies after jumping into Hillshire chase 3:44 p.m. May 29, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 3:52 p.m. May 12, 2014 - Sue Chang
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com
Internet, biotech could spawn next Apple: Allianz CIO 7:12 a.m. April 29, 2014 - Barbara Kollmeyer
Investors gloss over Biogen earnings miss and focus on MS drug sales 2:23 p.m. April 23, 2014 - Russ Britt
Scouring the moonscape for leading stocks 3:02 p.m. April 22, 2014 - The Trading Deck
Apple, Microsoft are not the keys to this week’s news 7:00 a.m. April 22, 2014 - Marek Fuchs
Long view on stocks is best during weak earnings season 6:00 a.m. April 20, 2014 - Wallace Witkowski
Biotech misses out on Nasdaq rally, sinks further into bear ground 4:58 p.m. April 14, 2014 - Russ Britt
Herbalife sinks on probe fears; Zoe’s surges on debut 4:37 p.m. April 11, 2014 - Sue Chang
Stocks fall for 3rd day in row; S&P 500 down for year again: stock market live blog recap 4:11 p.m. April 7, 2014 - blogs.marketwatch.com
Biotech bargain? 11:44 a.m. April 1, 2014 - The Trading Deck
Facebook, Biogen, Cal-Maine are stocks to watch 5:22 a.m. March 31, 2014 - Victor Reklaitis
U.S. stocks end week with losses 7:18 p.m. March 28, 2014 - Anora Mahmudova
Nasdaq pullback rife with opportunity 2:07 p.m. March 25, 2014 - The Trading Deck
Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - Russ Britt
U.S. stocks fall; Nasdaq skids 1.2% 4:41 p.m. March 24, 2014 - Anora Mahmudova
Biotech has second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - Russ Britt
First Solar extends winning streak; Symantec plunges 3:07 p.m. March 21, 2014 - Sue Chang

Coronado Falls on TSO Study Results - Analyst Blog 11:20 a.m. Today - Zacks.com
Auxilium/Sobi's Xiapex Filed for Label Expansion - Analyst Blog 5:00 p.m. June 26, 2014 - Zacks.com
Hottest Healthcare Stocks Now – PCRX ISRG SHPG BIIB 2:15 p.m. June 26, 2014 - InvestorPlace.com
Biogen Idec Has Lagged Its Biotech Peers, Now Is The Time To Shine! 11:17 a.m. June 26, 2014 - Seeking Alpha
Bristol-Myers Up on Nivolumab News - Analyst Blog 10:45 a.m. June 26, 2014 - Zacks.com
Prothena Corporation (PRTA) Falls: Stock Goes Down 5.3% - Tale of the Tape 8:43 a.m. June 26, 2014 - Zacks.com
Isis Pharma Gets $1M Milestone Payment from Glaxo - Analyst Blog 6:10 p.m. June 25, 2014 - Zacks.com
Ligand Pharma-TG Therapeutics Collaborate on IRAK4 Inhibitors - Analyst Blog 4:30 p.m. June 25, 2014 - Zacks.com
AbbVie Sets Rationale for Shire Bid 1:06 p.m. June 25, 2014 - The Wall Street Journal Interactive Edition
British Columbia to Reimburse TECFIDERA(TM), a First-Line Oral Treatment for Multiple Sclerosis 11:00 a.m. June 25, 2014 - CNW Group
XenoPort's XP23829 in Phase II Study - Analyst Blog 4:52 p.m. June 24, 2014 - Zacks.com
Insider Trading Alert - BIIB, FDS And GCO Traded By Insiders 10:45 a.m. June 24, 2014 - TheStreet.com
Stocks with Upgraded Broker Ratings - Screen of the Week 4:05 a.m. June 24, 2014 - Zacks.com
3 Stocks Reiterated As A Buy: MDLZ, BMY, BIIB 4:29 p.m. June 23, 2014 - TheStreet.com
AZN, AMGN And BIIB, Pushing Health Care Sector Downward 1:09 p.m. June 23, 2014 - TheStreet.com
AbbVie, Shire Give Bullish Guidance Amid Buyout Talk 10:24 a.m. June 23, 2014 - Investors Business Daily
Trade-Ideas: Biogen Idec (BIIB) Is Today's Momo Momentum Stock 10:32 a.m. June 20, 2014 - TheStreet.com
Celgene Rally Is for Real 9:11 a.m. June 20, 2014 - Barrons.com
Will Celgene Trigger Other Biotech Stock Splits? 1:19 p.m. June 19, 2014 - 247WallSt.com
ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart Attack Drug 9:27 a.m. June 19, 2014 - benzinga.com

Critical Alerts For Vertex Pharmaceuticals, Dollar Tree, Avis, Ryder, and Biogen Released By InvestorsObserver 9:31 a.m. June 25, 2014 - PR Newswire - PRF
True North Therapeutics Announces $22 Million Series A Financing 7:00 a.m. June 17, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Earns $10 Million Milestone Payment from Biogen Idec 7:00 a.m. June 17, 2014 - PR Newswire - PRF
Biogen Idec and AbbVie Announce Positive Top-Line Results from Phase 3 Study Investigating Daclizumab High-Yield Process in Multiple Sclerosis 7:30 a.m. June 16, 2014 - BusinessWire - BZX
Sobi to review preclinical data to potentially add future haemophilia A candidate to collaboration agreement with Biogen Idec 2:01 a.m. June 16, 2014 - Thomson Reuters ONE
One Year Post-Launch, All Surveyed U.S. Neurologists Report Having Clinical Experience with Biogen Idec's Tecfidera for the Treatment of Multiple Sclerosis 12:00 p.m. June 12, 2014 - PR Newswire - PRF
FDA Drug Approvals, Dividends, Fast Track Designation, Event Sponsorship, and Expansion of Role - Analyst Notes on Biogen Idec, UnitedHealth Group, GW Pharmaceuticals, Questcor and Cigna 5:10 a.m. June 11, 2014 - PR Newswire - PRF
RBCC to Expand Market for 'Underused' Addiction Treatment With New Technology 5:00 a.m. June 11, 2014 - BusinessWire - BZX
The Pulmonary Fibrosis Foundation Receives Grant From Biogen Idec To Support The PFF Patient Registry 11:00 a.m. June 10, 2014 - PR Newswire - PRF
Increased Credit Facility Commitments, Positions Moved, Survey Results, LEED Certification, and New Board Member Election - Analyst Notes on Prospect, Waddell & Reed, SEI, Alexandria and RPAI 5:20 a.m. June 10, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 1 Study of ISIS-DMPK Rx to Treat Myotonic Dystrophy Type 1 7:00 a.m. June 9, 2014 - PR Newswire - PRF
The US Food and Drug Administration (FDA) approves Eloctate(TM) 2:02 a.m. June 9, 2014 - Thomson Reuters ONE
FDA Approves Biogen Idec’s ELOCTATE™, First Hemophilia A Therapy to Extend the Interval between Prophylactic Infusions, for Both Adults and Children 4:55 p.m. June 6, 2014 - BusinessWire - BZX
FDA Approves Biogen Idec’s ELOCTATE™, First Hemophilia A Therapy to Extend the Interval between Prophylactic Infusions, for Both Adults and Children 4:46 p.m. June 6, 2014 - BusinessWire - BZX
Human Metabolome Technologies, Inc., (HMT) Hires Alexander Buko Ph.D. as Vice President, Business and Product Development and Releases a New C13 Flux Analysis Service, F-SCOPE. 3:27 p.m. June 6, 2014 - BusinessWire - BZX
Technical Snapshot on Biotech Stocks -- Research on Aegerion Pharma, Biogen Idec, Lexicon Pharma, and Curis 8:30 a.m. June 5, 2014 - PR Newswire - PRF
Critical Alerts For Tesla, Apple, Ryder System, ExOne, and Biogen Idec Released By InvestorsObserver 9:31 a.m. June 3, 2014 - PR Newswire - PRF
Upcoming Shareholders Meeting, Multi-Choice Medical Plans, FDA Approvals, and Investor Conference Schedules - Analyst Notes on Biogen Idec, UnitedHealth Group, Amgen, WellPoint and Mylan 7:00 a.m. June 3, 2014 - PR Newswire - PRF
Alexandria Real Estate Equities, Inc. Receives LEED Gold Certification for Biogen Idec Inc.'s Build-to-Suit Headquarters in Cambridge, Massachusetts 8:30 a.m. June 2, 2014 - PR Newswire - PRF
Data from Biogen Idec’s Portfolio of Multiple Sclerosis Therapies and Pipeline Featured at Medical Congresses 7:30 a.m. May 30, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cracking the Code of America's Delivery Addiction

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

HTX's Strategic Moves in Pakistan: A Crypto Frontier

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

The Chemical Industry and EPA: A Broken System?

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

K-Beauty Takes Front Stage at Target Beauty Studio

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Machine Grabs Prime Dallas Property Amid Apartment Boom

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Compass Unveiled: Power Revolution in Private Equity

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Sean Trahan Joins Citrin Cooperman: New Tax Lead

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

FJBio Boosts Antibody Discovery with Sapio AI

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Leapora's Taskeen: Redefining Task Accountability

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Anecdotes by Artists Brings Raw Scent Stories to Sephora

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...